Á¶¼®±¸ ¸íÀÇ

¸²ÇÁÁ¾ Áúȯ Àü¹®, ¼¼Æ÷Ä¡·á Ȱ¹ßÈ÷ ¿¬±¸

Á¶¼®±¸ ¸íÀÇ

  • ¼Ò ¼Ó
    °¡Å縯´ë¼­¿ï¼º¸ðº´¿ø Ç÷¾×Á¾¾ç³»°ú
  • Àü¹®ºÐ¾ß
    ¸²ÇÁ ¡¤ °ñ¼öÁ¾ , ¸é¿ª¼¼Æ÷Ä¡·á, Á¶Ç÷¸ð¼¼Æ÷À̽Ä, CAR-T ¼¼Æ÷Ä¡·á

Á¶¼®±¸ ±³¼ö´Â °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø Ç÷¿ªº´¿ø ¸²ÇÁ¡¤°ñ¼öÁ¾¼¾ÅÍÀåÀÌ´Ù. ¸²ÇÁÁ¾ Áúȯ Àü¹®°¡ÀÌ´Ù.
Á¶¼®±¸ ±³¼ö´Â ¸²ÇÁÁ¾ ºÐ¾ß¿¡¼­ ¿¬°£ 50¿©°ÇÀÇ Á¶Ç÷¸ð¼¼Æ÷À̽Ä, 500¸í »õ·Î¿î ȯÀÚ Áø·á¿¡ ³ª¼­°í ÀÖ´Ù. ÀÓ»ó Áø·á»Ó¸¸ ¾Æ´Ï¶ó ³­Ä¡¼º ÁúȯÀ» À§ÇÑ Áß°³¿¬±¸¸¦ À§ÇØ Á¤ºÎÁö¿ø ¿¬±¸µµ Ȱ¹ßÇÏ°Ô ¼öÇàÇϰí ÀÖ´Ù. ¶ÇÇÑ ¼­¿ï¼º¸ðº´¿ø¿¡¼­ ÀÚü °³¹ßÇÑ ¼¼Æ÷Ä¡·áÁ¦ Ȱ¿ëÇÏ¿© Ȱ¹ßÇÑ ÀÓ»ó ½ÃÇèÀ» ¼öÇàÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °¡Å縯´ëÇб³ ³»°úÇÐ ¹Ú»ç
  • °¡Å縯´ëÇб³ ³»°úÇÐ ¼®»ç
  • °¡Å縯´ëÇб³ ÀÇÇÐ Çлç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °¡Å縯´ë ±³¼ö, ÀÇ»ý¸í»ê¾÷¿¬±¸¿øÀå
  • úÞ) °¡Å縯´ë ¿¬±¸Ã³Àå, Áß°³ÀÇÇкÐÀÚ¿µ»ó¿¬±¸¼ÒÀå
  • úÞ) °¡Å縯´ë »êÇÐÇù·Â´ÜÀå, ÀÇ»ý¸í»ê¾÷¿¬±¸¿øÀå
  • ¼­¿ï¼º¸ðº´¿ø ¼¼Æ÷Ä¡·á¼¾ÅÍÀå (2009 ~ 2017)
  • ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø ¼¼Æ÷Ä¡·á»ç¾÷´ÜÀå (2013 ~ 2017)

¼ö»ó³»¿ª

Awards List
  • European Society for Blood and Marrow Transplantation - Best Young Abstract Award (2018)
  • The International Congress of Blood and Marrow Transplantation - Best Oral Presentation Award (2017)
  • The Asian Cellular Therapy Organization- ¿ì¼öÃÊ·Ï»ó (2015)
  • ´ëÇѸ鿪ÇÐȸ ¿ì¼ö±¸¿¬»ó (2015)
  • ´ëÇѳ»°úÇÐȸ ¿ì¼ö³í¹®»ó (2015)
  • ´ëÇÑÇ÷¾×ÇÐȸ ¿ì¼öÃÊ·Ï»ó (2012)

ÇÐȸȰµ¿

Academic activities
  • 2013 ~ ÇöÀçÇѱ¹½ÇÇèÇ÷¾×ÇÐȸÀå
  • 2017 ~ ÇöÀç American Association of Cancer Research International Member
  • 2007 ~ ÇöÀç European Hematology Association International Member
  • 2006 ~ ÇöÀçAmerican Society of Hematology International Member
  • 2003 ~ ÇöÀçJapanese Society of Hematology International Member
  • 2001 ~ ÇöÀç´ëÇѸ鿪ÇÐȸ Á¤È¸¿ø
  • ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ÆòÀÇ¿ø
  • ´ëÇѾÏÇÐȸ Á¤È¸¿ø
  • ´ëÇÑÇ÷¾×ÇÐȸ ÆòÀÇ¿ø
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Efficacy of ex vivo purging with CD34+selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö CYTOTHERAPY
Á¦ ¸ñ Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö FRONTIERS IN ONCOLOGY
Á¦ ¸ñ The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö SCIENTIFIC REPORTS
Á¦ ¸ñ Prognostic Value of FDG PET/CT in Patients with Nodal Peripheral T-Cell Lymphoma
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö DIAGNOSTICS
Á¦ ¸ñ A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö EXPERT OPINION ON BIOLOGICAL THERAPY
Á¦ ¸ñ Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö ANNALS OF HEMATOLOGY
Á¦ ¸ñ Diagnosis, treatment, and prognosis of primary intraocular lymphoma: Single-center real-world clinical experience
¹ßÇ¥³âµµ 2023 ¹ßÇ¥Áö CANCER MEDICINE

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°¡Å縯´ë¼­¿ï¼º¸ðº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1588-1511
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°¡Å縯´ë¼­¿ï¼º¸ðº´¿øÀº 1980³â °­³² Áö¿ª ÃÖÃÊÀÇ Á¾ÇÕº´¿øÀ¸·Î ¼¼¿öÁ³´Ù. ÇöÀç Áö»ó 22Ãþ, ÁöÇÏ 6ÃþÀÇ 1355º´»ó ±Ô¸ð¸¦ °®Ãß°í ÀÖÀ¸¸ç ´ÜÀÏ °Ç¹° º´¿øÀ¸·Î´Â ±¹³» ÃÖ´ë ±Ô¸ðÀÌ´Ù. °¡Å縯´ë¼­¿ï¼º¸ðº´¿øÀº °¡Å縯±³È¸ÀÇ ´ëÇ¥ º´¿øÀ¸·Î °¡Å縯Áß¾ÓÀÇ·á¿øÀÇ ÀÌ³ä ½Çõ¿¡ Àû±Ø ¾ÕÀå¼­°í ÀÖÀ¸¸ç, ȯÀÚ¸¦ ¸ÕÀú »ý°¢ÇÏ´Â Àü¹®¼¾ÅÍ Áß½ÉÀÇ º´¿ø, 21¼¼±â ÃÖ÷´Ü ÀÇ·á ½Ã½ºÅÛ º´¿øÀ¸·Î °Åµì³ª°í ÀÖ´Ù.

°¡Å縯´ë¼­¿ï¼º¸ðº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ¼­Ãʱ¸ ¹ÝÆ÷´ë·Î 222

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä